People | May 06, 2025
GMM Pfaudler Group appoints Gregory Gelhaus as Chief Transformation Officer
Gelhaus has a proven track record of driving business growth
Gelhaus has a proven track record of driving business growth
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
According to IQVIATM sales data for the 12-month period ending February 2025, the Adderall Tablets, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg market3 achieved annual sales of approximately $421.7 million.
The plant will have installed production capacity of 3,120 MT/month
According to IQVIA sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial) market achieved annual sales of approximately $39.3 mn
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
Indegene combines deep healthcare expertise with a digital-first approach to help pharma, biotech and medical device companies commercialize their products
Overall investment in the US facility is estimated around US$50 million
Subscribe To Our Newsletter & Stay Updated
